Citadel Advisors
CDMO

Citadel Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Citadel Advisors’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,300
Closed -$65.5K – 15989
2024
Q4 		$65.5K Sell
5,300
-22,000
-81% -$252K ﹤0.01% 12067
2024
Q3 		$311K Buy
27,300
+6,000
+28% +$60.2K ﹤0.01% 9269
2024
Q2 		$152K Sell
21,300
-29,200
-58% -$223K ﹤0.01% 10328
2024
Q1 		$338K Buy
50,500
+34,900
+224% +$240K ﹤0.01% 9211
2023
Q4 		$101K Buy
15,600
+9,700
+164% +$62.5K ﹤0.01% 10924
2023
Q3 		$55.7K Buy
5,900
+100
+2% +$1.2K ﹤0.01% 11628
2023
Q2 		$81K Sell
5,800
-900
-13% -$15.3K ﹤0.01% 11233
2023
Q1 		$126K Sell
6,700
-900
-12% -$14.8K ﹤0.01% 10927
2022
Q4 		$105K Sell
7,600
-8,100
-52% -$124K ﹤0.01% 11154
2022
Q3 		$300K Buy
15,700
+5,600
+55% +$102K ﹤0.01% 9589
2022
Q2 		$154K Sell
10,100
-35,600
-78% -$527K ﹤0.01% 10965
2022
Q1 		$931K Buy
45,700
+23,200
+103% +$472K ﹤0.01% 7871
2021
Q4 		$657K Sell
22,500
-7,700
-25% -$220K ﹤0.01% 8993
2021
Q3 		$651K Buy
30,200
+13,100
+77% +$316K ﹤0.01% 9250
2021
Q2 		$439K Buy
17,100
+1,200
+8% +$25.6K ﹤0.01% 10354
2021
Q1 		$290K Buy
+15,900
New +$264K ﹤0.01% 10939
2020
Q4 		– Sell
-10,300
Closed -$78K – 11649
2020
Q3 		$78K Sell
10,300
-8,700
-46% -$65.9K ﹤0.01% 9408
2020
Q2 		$125K Buy
+19,000
New +$106K ﹤0.01% 8866
2020
Q1 		– Sell
-14,100
Closed -$108K – 10324
2019
Q4 		$108K Buy
+14,100
New +$82.3K ﹤0.01% 8516
2019
Q3 		– Sell
-14,500
Closed -$81K – 9865
2019
Q2 		$81K Sell
14,500
-2,700
-16% -$11.1K ﹤0.01% 8597
2019
Q1 		$73K Buy
+17,200
New +$70.2K ﹤0.01% 8669
2017
Q3 		– Sell
-1,529
Closed -$7K – 8155
2017
Q2 		$7K Sell
1,529
-385
-20% -$1.58K ﹤0.01% 7384
2017
Q1 		$9K Sell
1,914
-2,157
-53% -$7.23K ﹤0.01% 7342
2016
Q4 		$9K Buy
4,071
+2,085
+105% +$4.87K ﹤0.01% 7158
2016
Q3 		$6K Buy
1,986
+472
+31% +$1.27K ﹤0.01% 7155
2016
Q2 		$4K Buy
1,514
+57
+4% +$159 ﹤0.01% 6753
2016
Q1 		$4K Sell
1,457
-872
-37% -$4.67K ﹤0.01% 6630
2015
Q4 		$19K Buy
2,329
+1,658
+247% +$13.4K ﹤0.01% 7973
2015
Q3 		$5K Sell
671
-572
-46% -$4.77K ﹤0.01% 8639
2015
Q2 		$11K Sell
1,243
-71
-5% -$683 ﹤0.01% 8385
2015
Q1 		$12K Sell
1,314
-72
-5% -$693 ﹤0.01% 8155
2014
Q4 		$13K Sell
1,386
-2,900
-68% -$29.2K ﹤0.01% 8049
2014
Q3 		$41K Buy
4,286
+2,315
+117% +$25.9K ﹤0.01% 7029
2014
Q2 		$26K Buy
1,971
+57
+3% +$719 ﹤0.01% 7169
2014
Q1 		$25K Buy
1,914
+1,528
+396% +$20.1K ﹤0.01% 7191
2013
Q4 		$4K Sell
386
-2,800
-88% -$26.3K ﹤0.01% 6852
2013
Q3 		$31K Sell
3,186
-2,943
-48% -$29.2K ﹤0.01% 6027
2013
Q2 		$55K Buy
+6,129
New +$64.2K ﹤0.01% 5614

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Citadel Advisors's CDMO Position: Q1 2025 in Review

Citadel Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 95,780 shares — an estimated $1.18M sold.

Citadel Advisors first reported a position in CDMO in Q2 2013 and held it in 38 quarters. The position peaked at $13.4M in Q3 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Citadel Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Citadel Advisors sold 95,780 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $1.18M.
  • Citadel Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 38 quarters.
  • Citadel Advisors's Avid Bioservices, Inc. Common Stock position peaked at $13.4M in Q3 2024.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.